Qiufang Lian
No. 38 Wenlin Road
Xianyang, 712000, China
Xianyang, 712000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Ginsenoside Rc exerts protective effects against cerebral ischemia‒reperfusion injury by boosting the Nrf2 pathway through targeted activation of Sirt1.
Journal: In vitro cellular & developmental biology. Animal
Published: June 04, 2026
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight.
Journal: The New England journal of medicine
Published: May 27, 2025
Efficacy and Safety of a Generic Clevidipine in Hypertensive Urgencies and Non-Fulminant Hypertensive Emergencies: A Phase III, Multicenter, Randomized, Double-Blind, Positive Drug Parallel-Controlled Study.
Journal: Journal of clinical hypertension (Greenwich, Conn.)
Published: May 12, 2025
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: The lancet. Diabetes & endocrinology
Published: March 25, 2025
Efficacy and safety of Shuxuening injection in patients with unstable angina: a multicenter, randomized, placebo-controlled trial.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 09, 2025
Efficacy and safety of Tafolecimab in Chinese patients with type 2 diabetes and hypercholesterolemia: a post-hoc analysis of pooled data from three phase 3 trials.
Journal: Cardiovascular diabetology
Published: January 21, 2025
Recaticimab in adult heterozygous familial hypercholesterolaemia (REMAIN-3): a multicentre, randomized, double-blind, placebo-controlled Phase 3 study.
Journal: Cardiovascular research
Published: December 09, 2024
Causal relationship between serum uric acid and cardiovascular disease: A Mendelian randomization study.
Journal: International journal of cardiology. Heart & vasculature
Published: May 22, 2024
Identification of atrial fibrillation-related genes through transcriptome data analysis and Mendelian randomization.
Journal: Frontiers in cardiovascular medicine
Published: April 09, 2024
Aucubin provides protection against cerebral ischaemia-reperfusion injury by suppressing neuronal apoptosis, oxidative stress, and inflammation through the modulation of the AKT-GSK-3β-Nrf2 signal cascade.
Journal: Toxicology and applied pharmacology
Published: September 15, 2023
Tafolecimab in Chinese patients with non-familial hypercholesterolemia (CREDIT-1): a 48-week randomized, double-blind, placebo-controlled phase 3 trial.
Journal: The Lancet regional health. Western Pacific
Published: May 31, 2023
Last Updated: 09/26/2026